Campaign Effectiveness Tracker for a US based Vaccine Company |
 | A US-based vaccine company newly launched its HPV vaccine in the Philippines. It ran targeted campaign to increase awareness about their vaccine. Read more to learn how we supported our client in tracking the campaign effectiveness among the HCPs. |
0 Comments
Evolution of Molecular Diagnostics Market - An Expert's Perspective (#2)
(Focus: India)
For our second interview in the "Evolution of Molecular Diagnostics Market - An Expert's Perspective" series, we interviewed Mr. Rajendra, Quality Assurance Manager, Strand Life Sciences, Bengaluru. Read this interview to learn about his experience and observations regarding the Indian cancer molecular diagnostics space.
 | Mr. Rajendra Kumar G S Quality Assurance Manager Strand Life Sciences, Bengaluru |
 | To mark the 'Cervical Cancer Awareness month', we present an infographic comparing the incidence and mortality data of Cervical cancer cases in the APAC vs RoW. |
By 2040, the mortality-related disease burden in the APAC11 countries will be similar to that in the Rest of the World (RoW), thus, indicating towards the high burden of Cervical cancer in this region.
Evolution of Molecular Diagnostics Market - An Expert's Perspective (#1)
(Focus: India)
Wishing all of our readers a great start to the year 2020!
We are kick-starting this year's 'Interview with an Expert' series with an insightful discussion with Dr. Ravi Gaur on the evolution and the dynamics of the cancer molecular diagnostics testing space in India.
Dr. Ravi Gaur is the Chief Operating Officer of Oncquest Labs and has more than 20 years of experience in the field of diagnostics. His stated goal is to make advanced diagnostics available at an affordable price and at doorstep of the customer.
Click on 'Read More' to learn about his views on how cancer molecular diagnostic testing space has evolved over the years and the key emerging trends and challenges in this segment.
We are kick-starting this year's 'Interview with an Expert' series with an insightful discussion with Dr. Ravi Gaur on the evolution and the dynamics of the cancer molecular diagnostics testing space in India.
Dr. Ravi Gaur is the Chief Operating Officer of Oncquest Labs and has more than 20 years of experience in the field of diagnostics. His stated goal is to make advanced diagnostics available at an affordable price and at doorstep of the customer.
Click on 'Read More' to learn about his views on how cancer molecular diagnostic testing space has evolved over the years and the key emerging trends and challenges in this segment.
 | Dr. Ravi Gaur AM, MBBS, MD, MS Chief Operating Officer (COO), Oncquest Labs Ltd., New Delhi, India |
Service Gap Assessment for a US-based Medical Device Company
(Focus: Singapore)
 | A US-based leading medical device manufacturer launched its new endoscopy product in Singapore. Read more to learn how we supported them in identifying and designing a differentiated after sales support policy. |
Pancreatic Cancer - A Basic Understanding
(Focus: Malaysia)
As mentioned in our earlier post, November is also for raising awareness about Pancreatic Cancer. Here is the transcript of our interview with Dr Sujit Chakraborty, Clinical Oncologist from Hospital Lam Was Ee, Malaysia.
Dr. Sujit Chakraborty is a specialist in Cancer Treatment, mainly in Medical Oncology and Radiotherapy. He has 27 years of experience in treating and managing cancer patients, both surgically and via radiotherapy. He has been actively involved in various Cancer Awareness programmes.
Dr. Sujit Chakraborty is a specialist in Cancer Treatment, mainly in Medical Oncology and Radiotherapy. He has 27 years of experience in treating and managing cancer patients, both surgically and via radiotherapy. He has been actively involved in various Cancer Awareness programmes.
|
Dr Sujit Chakraborty MBBS, MD Clinical Oncologist, Hospital Lam Wah Ee, Malaysia |
Lung Cancer - A Basic Understanding
(Focus: India)
As November is marked for raising awareness about Lung Cancer and Pancreatic Cancer, this month we are bringing to our readers observations/views of two of our highly experienced panel members. Below is the transcript of our interview with Dr. Bivas Biswas, Medical Oncologist from the Tata Medical Center, Kolkata.
He has 10+ years of experience in treating cancer patients and is actively involved in teaching/training medical students. He also is Section Editor in Indian Journal of Medical & Pediatric Oncology and is involved in reviewing journals like - Indian Journal of Pediatrics, BMC cancer, and Journal of Urology .
He has 10+ years of experience in treating cancer patients and is actively involved in teaching/training medical students. He also is Section Editor in Indian Journal of Medical & Pediatric Oncology and is involved in reviewing journals like - Indian Journal of Pediatrics, BMC cancer, and Journal of Urology .
|
Dr. Bivas Biswas DM [Medical Oncology, AIIMS] , MD [AIIMS], MBBS Medical Oncologist, Tata Medical Center, Kolkata |
|
November is the Pancreatic Cancer Awareness month. We present an infographic comparing the incidence and mortality data of Pancreatic cancer in the APAC vs RoW. |
In APAC 11 countries, the rate of increase in incidence and mortality is expected to be higher (by > 10%) compared to the Rest of the World.
Go-to-Market Strategy for a UK based Diagnostics Company
(Focus: India)
|
A UK based diagnostics company providing Fluorescence in situ hybridization (FISH) based rapid tests has plans to enter the Indian market. Read more to know how we supported them in designing a Go-to-Market strategy by conducting a detailed market assessment.
|
Quantitative Brand Name Testing for a Global Medical Device Company
(Focus: APAC)
Our client needs support in finalizing on a brand name that would best represent their portfolio of companion diagnostics services. Read more to know how we used quantitative brand name testing exercise to support the client.